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Abstract
Food allergies affect an estimated 3 to 4% of adults and up to 8% of children in developed western
countries. Results from in vitro simulated gastric digestion studies with purified proteins are
routinely used to assess the allergenic potential of novel food proteins. The digestion of purified
proteins in simulated gastric fluid typically progresses in an exponential fashion allowing persistence
to be quantified using pseudo-first-order rate constants or half lives. However, the persistence of
purified proteins in simulated gastric fluid is a poor predictor of the allergenic status of food
proteins, potentially due to food matrix effects that can be significant in vivo. The evaluation of the
persistence of novel proteins in whole, prepared food exposed to simulated gastric fluid may
provide a more correlative result, but such assays should be thoroughly validated to demonstrate
a predictive capacity before they are accepted to predict the allergenic potential of novel food
proteins.
Background
The adult human gastrointestinal tract (GI) is a tube
approximately 9 meters long, running through the body
from the mouth to the anus. The lumen of the GI tract is
continuous with the external environment, keeping its
contents outside of the rest of the body. The epithelial
layer, which lines the interior of the GI tract, presents a
partial barrier to invasion by ingested pathogens, para-
sites, toxins and antinutrients. If pathogens, toxins and
food proteins breach the epithelium barrier, the immune
system acts as our primary defense system. Antibodies are
formed that specifically react with epitopes on certain
antigenic proteins, and subsequent binding of subtypes of
these antibodies to proteins can result in the mobilization
of host defenses, including deleterious responses like
allergy.
The GI tract helps prevent food antigen penetration
through its gut epithelial barrier. Epithelial cells are joined
together with their neighbors via tight junctions and
mucus produced by goblet cells [1]. In the upper bowel,
the bulk of antigen exposure comes from foods, while in
the lower bowel, the antigenic load comes from the com-
plex microflora living in the GI tract. In addition to serv-
ing as a barrier, the mucosal system has two robust
adaptive immune mechanisms to prevent general antigen
circulation: (i) antigen exclusion mediated through the
secretion of IgA and IgM antibodies to modulate the col-
onization of microorganisms and dampen penetration of
soluble luminal agents, and (ii) suppressive mechanisms
to avoid hypersensitivity to substances present in the
mucosal surface [2]. The latter mechanism is known as
oral tolerance when it is induced by food antigens [3].
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absorbed and distributed in the body. Intact food proteins
can be detected in plasma [4-6] and gut bacteria can be
detected in mesenteric lymph nodes [7]. An estimated 3 to
4% of adults and up to 8% of children suffer from food
allergies in developed western countries [8,9]. In the west-
ern world, most infectious diseases of the gut are largely
under control, yet food allergies are considered to be a
major health concern. Food allergy accounts for up to
50% of anaphylactic episodes resulting in hospitaliza-
tions [10,11].
Failure of oral tolerance leading to food allergies is most
often due to an IgE-mediated hypersensitivity to a small
subset of proteins found in milk, eggs, peanuts, fish, shell-
fish, soy, wheat and tree nuts [12]. Typical diets contain
tens of thousands of different proteins, and efforts to
understand the unique physiochemical and molecular
properties of food allergens are ongoing [13-15].
The exact site of food absorption and allergy induction is
still unknown. It is believed that most food allergens are
absorbed in the intestines, prior to initiating an immune
response, requiring proteins to move through the stom-
ach in an immunologically intact form. Food protein can
also enter the circulation through the oral mucosa
[16,17]. Certain disease conditions, such as celiac disease,
can increase the amount of intact proteins in general cir-
culation [18].
The majority of ingested food proteins break down as they
travel through the GI tract. This occurs through the proc-
esses of digestion, where the food is exposed to the dena-
turing environment of hydrochloric acid in the stomach,
bile from the liver and digestive enzymes released by the
salivary glands, chief cells in the stomach, and the pan-
creas. The proteases and peptidases produced and secreted
by chief cells and the pancreas digest proteins into small
peptides typically less than 8 amino acids in size [19]. This
extensive digestion renders these peptides non-reactive for
antigen recognition [20]. For this reason, resistance to
proteolysis has been considered a promising indicator of
allergenic potential [21]. More recently Utersmayr and
Jensen-Jarolim [22] have shown that antiulcer agents
increase the risk of food allergy by interfering with the
digestive function and decreasing the threshold of aller-
gens required to elicit symptoms in patients with food
allergy. Therefore, when the gastric digestion of a protein
is impaired or limited, protein persistence increases,
potentially triggering sensitization or allergic symptoms.
This phenomenon is known as allergen persistence [22].
Based on the relationship between GI digestion and food
allergy, results of in vitro digestion experiments have been
considered to assess the allergenic potential of new food
proteins. In this paper, we review the influence of gastric
digestion on the development of food allergy, and evalu-
ate the currently applied digestion assays for testing the
allergenic potential of novel food proteins. We start by
defining a food allergen, and then discuss the standard
simulated gastric fluid digestion (SGF) assay currently
used to assess allergenic potential of food proteins. We
found that results from SGF assays with pure proteins are
not a good predictor of the allergenic potential of food
proteins, but rather that they simply measure the resist-
ance of purified food proteins to in vitro digestion. More-
over resistance to SGF is not a sufficient or useful criterion
for evaluating food allergen sensitization or induction.
What is a food allergen?
Before we discuss the use of digestion experiments for pre-
dicting the allergenic potential of food proteins, we must
define a "food allergen". This term is general and ambigu-
ous. Food allergens have at least three potential attributes:
(1) Induction of allergic sensitization.
(2) Reaction with IgE antibodies
(3) Induction of allergic reactions.
The food proteins which do all three of the above are
known as complete food allergens [23], while the others
are called incomplete food allergens. Incomplete food
allergens are divided into two categories [24]: (i) non-elic-
itors, which do (2), but not (1) or (3), and (ii) non-sensi-
tizing elicitors, which do (2) and (3), but not (1). Bannon
[25] suggests that complete allergens are resistant to diges-
tion in the GI tract, while incomplete allergens are poten-
tially susceptible to digestion in the GI tract [26,27].
The standard digestion assay to assess allergenic potential 
of food proteins
Digestion assays in simulated gastric fluid (SGF) are com-
monly employed to predict the allergenic potential of
food proteins [28-31], and are currently required as part
of the allergenicity assessment of transgenic proteins
expressed in food crops [32,33]. Astwood et al. [34] used
the SGF assays to investigate the stability of 25 food pro-
teins to pepsin. The hypothesis was that food allergens
would survive the acidic gastric environment and resist
digestion by pepsin in the stomach to reach the intestinal
mucosa and be absorbed, while non-allergens would not
[35]. Astwood et al. [34] found that the stability to diges-
tion is significant in the selected food allergens, and con-
cluded that digestion is a valid parameter that
distinguishes food allergens from non-allergens.Page 2 of 7
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As a result of the Astwood et al. [34] report, the SGF assay
has been incorporated in the decision tree or weight-of-
evidence approach to evaluate the allergenic potential of
novel food proteins that may be present in food crops
[32,33]. The SGF assay has been standardized to facilitate
comparisons among substrates [36]. This recipe specifies
0.32% pepsin in hydrochloric acid at a pH of 1.2. SGF was
developed to provide a model system for mammalian
monogastric digestion and has been used to evaluate the
relative nutritional value of different protein sources, and
the dissolution of pharmaceuticals [37,38]. It is widely
understood that the SGF assay does not actually replicate
the gastric environment but only represents a standard-
ized model system for proteolysis under acidic condi-
tions. The SGF assay was first used to systematically
evaluate the gastric stability of allergenic food proteins by
Astwood et al. [34]. In this study, 0.017% protein sub-
strate was incubated in SGF (0.32% pepsin, pH 1.2) at
37°C.
Pepsin is an aspartic protease generated from the auto-
cleavage of pepsinogen under the acidic conditions in the
stomach. Pepsin has broad substrate specificity, preferen-
tially cleaving proteins at leucine, phenylalanine and tyro-
sine [39]. Pepsinolysis is generally very rapid unless
hindered by the secondary or tertiary structure of the pro-
tein substrate [40-42]. The optimum pH for pepsinolysis
is between 1.8 and 3.2, and pepsin is irreversibly dena-
tured at pH 6 to 7 [39,43]. This latter property of pepsin
allows the SGF reaction to be stopped by neutralizing aliq-
uots of the solution after different incubation periods.
These aliquots can then be analyzed to track the digestion
of substrate proteins.
The analytical tool generally used to track the digestion of
substrate protein in SGF is sodium dodecyl polyacrylim-
ide gel electrophoresis (SDS-PAGE). SDS-PAGE separates
denatured proteins on polyacrylamide gels based prima-
rily on molecular mass, and thus does not distinguish
enzyme-bound from non-bound substrate. Proteins are
visualized by staining with various dyes such as colloidal
Coomassie brilliant blue. While the density of stained
bands is generally directly proportional to the protein
concentration for any given protein [31,44,45], different
proteins have different propensities to bind stain [46].
Thus, the relative concentration of any given protein can
be tracked through time, but comparisons of concentra-
tion across different proteins are not accurate based solely
on band densities. It also follows that the minimum con-
centration that can be visualized on SDS-PAGE gels differs
among different proteins. An example of the dramatic dif-
ference in protein staining between two proteins can be
seen in Figure 3 in Thomas et al. [38]. In panel B of this
figure, the pepsin to ovalbumin ratio is 3:1 w/w, however
the ovalbumin band at time zero, prior to digestion, is
much darker than the pepsin band.
In some cases, discrete smaller-molecular-weight protein
fragments appear, and sometimes disappear, as digestion
progresses [38,47]. These digestion fragments may be
capable of eliciting an allergic reaction if they have at least
two IgE binding sites (epitopes) and are of sufficient size
(> 3 kDa) such that the antibody-protein complex can
cross-link two receptors on the surface of mast cells caus-
ing the cascade of effects leading to an allergic reaction
[48]. It is noteworthy that when fragments are seen, they
universally appear as discrete bands rather than as smears
of many different molecular-weight peptides, indicating
that specific fragments likely retain some level of second-
ary and/or tertiary structure that hinders pepsinolysis.
Patterns of digestion in the simulated gastric fluid assays
The SGF assays can produce complex patterns of diges-
tions in SDS-PAGE gels. These patterns revolve around the
multiple cleavage sites on the protein substrate rather
than from the presence of multiple enzymes or compart-
ments. However, the digestion of the substrate protein
generally follows an exponential decline.
The SGF assay is similar to other dissipation experiments,
which are conducted to track the disappearance of sub-
strates in complex systems. One example is the tracking of
pest-control substances in soil. Microbial digestion of
compounds, via many enzymes, in soil often predomi-
nates in such systems, and in spite of the complexity of the
processes, dissipation of substrate often closely follows a
negative exponential pattern [49,50]. Similarly, the clear-
ance of pharmaceuticals from blood also is the result of
complex processes often including enzyme catalyzed
cleavage, but still generally follows an exponential decline
pattern [51]. This same pattern has been observed in a
number of in vitro protein-protease systems [52], particu-
larly in proteolysis assays under acid-denaturing condi-
tions [53] and pepsinolysis [42,54]. The exponential
decay pattern is sometimes biphasic but the final phase of
digestion most often follows pseudo-first order kinetics
[55]. The progress of the digestion seems to be quite
insensitive to variation in both the pepsin concentration
and the substrate protein concentration as long as the
pepsin concentration is close to that specified in the USP
(0.32%), and the substrate protein concentration is rela-
tively low [31,47,56,57].
There are four possible explanations for the biphasic and
pseudo-first order decay pattern observed in proteolysis
experiments: (i) Protein digestion is dominated by a first-
order rate-limiting step. A possible rate-limiting step can
be the acid-induced unfolding of the protein under the
low pH (1.2) of SGF [42,58]. Unfolding rates have oftenPage 3 of 7
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ing occurs, pepsinolysis can proceed very quickly. This
would result in apparent exponential disappearance of
protein substrate in SGF. (ii) Protein digestion follows
pseudo-first-order kinetics [59] under the excess of the
digestive enzyme. This is the theory generally used to
explain the first-order behavior of protein digestion in
SGF [45,52,56,57,60,61]. (iii) In protein digestion assays
there is an exponential decay, which is only applicable to
the slow transient of the digestion reaction at high
enzyme concentrations. Schnell and Maini [62] and Tzaf-
riri [63] have shown that enzyme catalyzed reactions can
be described by a first-order kinetics after the initial tran-
sient of the reaction at high enzyme concentrations. (iv)
The aggregate behavior of complex reactions, such as pro-
tein digestion, produces a behavior indistinguishable
from the first-order kinetics [64]. Recent computational
models have shown that the later theory (iv) provides a
compelling explanation for the exponential decay in pro-
tein digestion assays [55].
Is it appropriate to assess the allergenic potential using 
digestion assays?
While the predictive power of the SGF assay has been
promulgated in a number of papers [28-31], and is
required as part of the allergenicity assessment of trans-
genic proteins expressed in food crops [32,33], the predic-
tive power of the assay remains uncertain [47,54,65,66].
Using simulated SGF assays [36], Astwood et al. [34] orig-
inally found a good correlation between allergenic status
and susceptibility to pepsin under acidic conditions. It
was this work that initially prompted the use of the SGF
assay to predict the allergenic potential of novel food pro-
teins. However, Fu et al. [65] noticed a confounding factor
in the Atwood et al. study. The cellular functions of the
proteins evaluated in this investigation were correlated
with the allergenic status of the proteins. When a group of
allergens and non-allergens were chosen by the latter
researchers that controlled for cellular function, the corre-
lation was absent. More recently, Herman et al. [47] found
no correlation between the digestibility and allergenic sta-
tus of seven allergens and eight non-allergens.
Likely reasons for the poor predictive capability of this
assay include a lack of consideration of the prevalence of
the allergen in food, effects of food processing, and food-
matrix interactions [67-73]. The latter factor may be very
important since components of food may sequester cer-
tain proteins away from the acid and pepsin in gastric
fluid. For example, Polovic et al. [73] found that the puri-
fied kiwi allergen, Act c 2, was digested quickly in SGF, but
was protected from digestion by fruit pectin both in vitro
and in vivo. Similarly, Chikwamba et al. [67] found that
transgenic corn expressing the Escherichia coli heat-labile
enterotoxin facilitated the association of this protein with
starch granules that protected it against digestion in SGF.
Thus the evaluation of purified proteins in the SGF assay
may be misleading.
Also there are a number of complete or potent allergens
which are not stable in SGF assays [65,66,74], but their
peptide fragments are recognizable by allergen-specific T
cells [75]. Digestion outcomes can be influenced by the
concentration of substrate protein or pepsin, pH and
other factors [76]. Protein allergens of food sources like
milk [77], fish [17,78] and hazelnut [75] can be digested
in vitro, unless the digestion process is inhibited by ant-
acid medication [22]. In the later case, there is an
increased risk of food allergy. The sudden increase of food
allergy by inhibiting digestion suggests that the concentra-
tion of allergens reaching the intestinal mucosa is impor-
tant in triggering an allergic reaction [79]. A similar
phenomenon is observed with gastro-intestinal inflam-
mation diseases, which can increase gut-permeability
prior to food allergen contact [7]. This does not imply that
allergens are more likely to be stable to digestion in simu-
lated gastric fluid compared with non-allergens, but rather
it suggests that if the concentration of a food allergen
increases, then the chance of protein absorption is also
higher. Once food allergens permeate the GI tract, they
will stimulate the immune system to produce IgE antibod-
ies, and degranulate mast cells upon subsequent contact
leading to an allergic reaction.
Food allergies are complex, and can be the result of com-
plex interactions. There are also food allergens which can
only cause symptoms under cross-reactivity conditions.
For example, pollen-allergic patients frequently present
food allergies after the ingestion of several plant foods
[24]. On the other hand, the mechanisms of how some
patients with IgE to ovalbumin tolerate eggs, while others
do not, remains unclear [23]. Digestion assays can neither
predict the effects of cross-reactivity between food aller-
gens and other antigens, nor the allergic response of a
patient to food protein [80].
Conclusion
Although the value of comparing the stability of proteins
in SGF for the purpose of evaluating the allergenic poten-
tial of novel food proteins is dubious, such comparisons
are routinely used for this purpose. The nature of allergy
to food proteins is still unknown. At the moment, we
know that the resistance to in vivo digestion of an aller-
genic food protein increases its potential for causing an
allergic reaction in susceptible individuals. We also know
that some peptide fragments of digested proteins can be
recognizable by allergen-specific T cells. However, the
amount of food protein and the condition under which
can trigger the allergic reaction are largely unknown [81].Page 4 of 7
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assay to test food proteins
The limitations of the SGF assays for predicting the aller-
genic potential are becoming apparent to the food allergy
community [47,54,65,66,74]. In light of the limitations
of the SGF assays, Utersmayr and Jensen-Jarolim [22] sug-
gested the introduction of a new concept in the food aller-
gen community: allergen persistence. Slow or impaired
digestion of food proteins which are potential allergens
increases the risk for food allergy induction in sensitized
individuals. Although SGF assays with purified proteins
cannot predict allergenic potential, they can quantita-
tively estimate the food protein persistence in the GI tract
if food-matrix effects are not significant. If a novel food
protein is an allergen, then a dose increase in the GI tract
can exceed the threshold for triggering an allergic reaction
in sensitized individuals. The typical protein absorption
time correlates with gastric transit time determined for
pharmaceutical compounds [82].
A kinetic approach to measuring SGF digestion is cur-
rently the most reasonable method to quantitatively com-
pare the persistence of purified food proteins during in
vitro digestion [42,45,47,54,56]. The digestion of proteins
in SGF typically conforms to a negative-exponential
model allowing first-order rate constants or half lives to
characterize the disappearance of substrates over their dis-
sipation profile. This approach provides an in vitro meas-
ure of the persistence of food proteins.
Apart from the quantitative estimates of protein persist-
ence, other aspects of the SGF assay protocol can also be
improved. The evaluation of the persistence of novel pro-
teins in whole, prepared food exposed to SGF [83] may
provide better estimates of in vivo persistence of food pro-
teins. The proteolysis of food proteins can be affected as a
result of processing and interaction with food ingredients.
For example, β-lactoglobulin proteolysis by trypsin and
chymotrypsin is reduced in the presence of polysaccha-
rides such as gum arabic, low methylated pectin or xylan
[84]. Peanut protein digestibility is also reduced in the
presence of gum Arabic and xylan [85]. Finally new assays
have been proposed to model more realistically the multi-
phase nature of the digestive processes [75,84,86]. These
digestion assays mimic the passage of the food into the
stomach and then into the gut. The development of these
digestion assays has demonstrated the importance of
using physiologically relevant conditions to investigate
the digestion of food proteins in vitro [69]. Some of these
models have been recently reviewed in [76].
We emphasize that the persistence to SGF in vitro provides
little value in the absence of evidence that a particular pro-
tein can induce IgE antibodies or elicit an allergic
response. The allergenic potential of a food can only be
diagnosed through sensitive analytical methods which
recognize the presence of allergenic antigens in food. For
novel food proteins, where populations of allergic indi-
viduals are absent or limited, results from SGF assays with
pure proteins are of little value in predicting allergenicity.
Continued work on new animal models of sensitization
for food proteins will be of critical importance for accu-
rately predicting the allergenicity of novel food proteins
[87]. SGF assays should be employed for estimating pro-
tein persistence in vitro and isolating peptide fragments
with potential allergenic epitopes. Therefore the assess-
ment of food allergen requires the use of both digestion
and immunology assays as a means to ensure consumer
safety to food proteins.
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